Espumizan l emulsion for vn.pr. 40mg / ml, 30ml vial cap.

Description

Composition
Active substance:
1 ml of drops contain: Simethicone * – * 40.00 mg Simethicone consists of dimethicone (polydimethylsiloxane (PDMS)) and silica in a ratio of 96: 4.
Excipients:
Macrogol stearate – 6,560 mg, glyceryl monostearate 40-55 – 4,020 mg, carbomer – 6,350 ml Banana Flavor – 4,233 mg, acesulfame potassium – 0.318 mg sorbitol liquid (nekristalliziruyuschiysya) – 211.655 mg Sodium chloride – 0.708 mg of sodium citrate – 4.445 mg sodium hydroxide, – 0.708 mg sorbic acid – 1.060 mg purified water – 778.245 mg.
Description:
Slightly viscous emulsion is milky white odor of banana.
Product form:
The emulsion for oral administration, 40 mg / ml. 30 ml dark glass vials provided with a dropper-dispenser screw cap to the control system of the first opening and the measured cap.
1 bottle along with instructions for medical use in a cardboard package.
Contraindications
Increased sensitivity to the drug, ileus, hereditary fructose intolerance.
Dosage
40 mg / ml
Indications
The symptoms of colic in infants; excessive formation of symptoms and accumulation of gases in the gastrointestinal tract (including bloating, flatulence in the postoperative period); Symptoms of excessive gas formation, caused by functional dyspepsia; preparation for a diagnostic test of abdominal cavity and the pelvic (ultrasound, radiography, esophagogastroduodenoscopy et al.), including, as an additive for suspensions of contrast agents for imaging double contrast method; acute poisoning detergents containing foaming agents (surfactants) as a defoamer.
Interaction with other drugs
No clinically significant drug interactions Espumizan® L with other drugs is not established.
Overdose
Cases of overdose are not known.
pharmachologic effect
Pharmacological group:
Carminative.
Pharmacodynamics:
Active ingredient – simethicone reduces the amount of gases in the gastrointestinal tract (GIT) has surfactant properties and the ability to reduce surface tension at the liquid / gas medium, which hinders the formation of gas bubbles, and promotes their coalescence and foam collapse in intestines, whereupon the released gas is sucked and removed naturally under the influence of intestinal peristalsis. Simentikona Application in preparation for diagnostic studies prevents the occurrence of image defects caused by gas bubbles.
Pharmacokinetics:
Simethicone is chemically inert after ingestion is not absorbed from the digestive tract and acts only in its lumen. It does not interact with microorganisms and enzymes and does not affect the process of digestion. Displayed intestine in an unmodified form.
Pregnancy and breast-feeding
The drug Espumizan® L can be used during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
Side effects associated with use of the drug L Espumizan® not observed.
May develop allergic reactions to the auxiliary components of the preparation.
special instructions
In case of preservation excessive gassing and / or intestinal colic for a long time is necessary to contact a physician for a medical examination.
Preparation Espumizan® L contains sorbitol (sorbitol), and therefore its use in patients with hereditary fructose intolerance contraindicated.
Information for patients with diabetes mellitus: 1 ml (25 drops) contains sorbitol 211.655 mg which corresponds to 0.018 bread units (BU).
Effect on ability to drive vehicles and management mechanisms
The drug Espumizan® L does not affect the ability to drive vehicles and work requiring high concentration.
Storage conditions
Store at temperatures not above 25 C. Do not freeze!
Keep out of the reach of children!.
Dosing and Administration
Inside. Before use, the vial of emulsion necessary to shake. Preparation can be dosed in milliliters or drops using a measuring cup. Drip dispensing bottle must be held vertically down hole.
The drug is taken during or after a meal, and when necessary – before going to bed.
Multiplicity receiving and duration of application depend on the severity of symptoms. If necessary, the drug Espumizan® L can be taken for a long time
In case of complaints associated with excessive flatulence and colic
Children from birth to 1 year: 1 ml (25 drops) Espumizan® L of the drug in each child feeding (add in baby bottles or provide with a small spoon during or after feeding).
Children from 1 year to 6 years: 1 ml (25 drops) of the drug Espumizan® L 3-5 times a day.
Children aged 6 to 14 years of age: 1-2 ml (25-50 drops) preparation Espumizan® L 3-5 times per day.
Children of 14 years and adults: 2 ml (50 drops) preparation Espumizan® L 3-5 times per day.
In preparation for the radiography and ultrasonography
Applied to 2 ml (50 drops) preparation Espumizan® L 3 times a day on the day before the study and 2 ml (50 drops) preparation Espumizan® L morning of the study.
To obtain double contrast images
Add 4-8 ml of the preparation Espumizan® L per 1 liter contrast slurry.
In preparation for esophagogastroduodenoscopy
Inside 4-8 ml of the preparation Espumizan® L prior to the study. During endoscopy, if necessary, can introduce several milliliters of emulsion through the endoscope channel for removing gas bubbles interfering with study.
In acute poisoning detergents containing surfactants.
Babies – of 2.5-10 ml of the preparation Espumizan® L, adults – 10-20 ml of the preparation Espumizan® L depending on the severity of poisoning.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist